Updated Today
If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Jan 1, 2027, then the market resolves to Yes.
As of March 27, 2026, the Kalshi odds for When will COMPASS Pathways plc submit a NDA for COMP360 psilocybin to the FDA? are: before April 2027: 75%, before 2027: 70%, before December: 53%, before November: 38%, before October: 12%. These probabilities are derived from real-money trading and update in real time.
When will COMPASS Pathways plc submit a NDA for COMP360 psilocybin to the FDA? is currently available on Kalshi. Check PredictMarketCap for cross-platform availability as new markets are added regularly.
Prediction market odds reflect the aggregate opinion of traders who risk real money on outcomes. The price of a share (e.g., 65¢) represents the market's implied probability (65%). Prices move as traders buy and sell based on new information, polls, and analysis.